🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Drugs used in chemotherapy, such as 17-N-allylamino-17-demethoxy...
Status
Completed
Location
Jonsson Comprehensive Cancer Center at UCLA
Start Date
2004-10
Trial ID
NCT00100997
Treatments Being Tested
RATIONALE: Panobinostat and imatinib mesylate may stop the growth of cancer...
Status
Completed
Location
City of Hope Medical Center
Start Date
2008-05
Trial ID
NCT00686218
The purpose of this study is to determine a maximum tolerated dose and/or r...
Status
Completed
Location
Dana Farber Cancer Institute SC (2)
Start Date
2012-04-20
Trial ID
NCT01468688
To test the efficacy of a combination chemotherapy of imatinib and 5-FU in ...
Status
Completed
Location
Krankenhaus Nordwest
Start Date
2007-04
Trial ID
NCT01153750
Treatments Being Tested
This is a multicenter, open label, Phase 1 dose-escalation study of BBI608 ...
Status
Completed
Location
Rocky Mountain Cancer Centers
Start Date
2015-05
Trial ID
NCT02352558
Treatments Being Tested
In this phase I study, the investigators will determine the maximum tolerat...
Status
Completed
Location
Tennessee Oncology, PLLC
Start Date
2004-07
Trial ID
NCT00611689
Treatments Being Tested
RATIONALE: Imatinib mesylate may stop the growth of cancer cells by blockin...
Status
Completed
Location
Cleveland Clinic Taussig Cancer Center
Start Date
2003-07
Trial ID
NCT00268229
Treatments Being Tested
This study evaluates the efficacy and safety of surgical intervention in pa...
Status
Unknown
Location
Multiple Locations
Start Date
2019-07
Trial ID
NCT03862768
Treatments Being Tested
Primary objective To determine maximum tolerated dose \& dose limiting toxi...
Status
Completed
Location
Duke University Health System
Start Date
2005-05
Trial ID
NCT00613132
Treatments Being Tested
The purpose of this study is to look at a subset of plexiform neurofibromas...
Status
Withdrawn
Location
Riley Hospital for Children - Indiana University
Start Date
2018-09-01
Trial ID
NCT03688568
Treatments Being Tested